Stem Cell Infusions Investigated for Treatment of COVID-19 ARDS

FRIDAY, Jan. 15, 2021 -- Researchers are exploring the potential immunomodulatory and anti-inflammatory effects of umbilical cord mesenchymal stem cell (UC-MSC) infusions for acute respiratory distress syndrome (ARDS) in COVID-19, according to a...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news